Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Naunyn Schmiedebergs Arch Pharmacol ; 390(11): 1163-1172, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28821921

ABSTRACT

Stigmasterol is a common sterol found in plants, but the anti-nociceptive effect of this compound and its mechanism of action are not fully explored. Thus, in the present study, the anti-nociceptive effect of stigmasterol was investigated in acute and chronic models of pain and its mechanism of action. We used adult male albino Swiss mice (25-35 g) to observe the anti-nociceptive effect of stigmasterol in acetic-acid writhing test or in complete Freund's adjuvant injection, surgical incision in hind paw, or partial sciatic nerve ligation. Moreover, we investigate the involvement of opioid receptors (naloxone, 2 mg/kg, intraperitoneally) in stigmasterol anti-nociceptive effect and stigmasterol action on acetylcholinesterase activity. Some possible adverse effects caused by stigmasterol were also investigated. Stigmasterol (0.3-3 mg/kg, orally) exhibited an anti-nociceptive effect on acetic-acid-induced writhing test. Furthermore, it markedly attenuated the mechanical allodynia caused by surgical incision (after acute treatment with stigmasterol, preventive and curative effects were observed) and partial sciatic nerve ligation (after acute treatment with stigmasterol) and complete Freund's adjuvant (after acute or repeated treatment with stigmasterol). The anti-nociceptive effect of stigmasterol was not reversed by naloxone. Moreover, stigmasterol did not alter in vitro acetylcholinesterase activity in spinal cord or brain samples. Also, stigmasterol did not cause gastric ulcers or alter the gastrointestinal transit of mice. Taken together, these results support the potential anti-nociceptive effect of stigmasterol in different models of pain.


Subject(s)
Analgesics/therapeutic use , Hyperalgesia/drug therapy , Pain/drug therapy , Stigmasterol/therapeutic use , Acetic Acid , Acetylcholinesterase/metabolism , Acute Disease , Animals , Brain/drug effects , Brain/metabolism , Chronic Disease , Freund's Adjuvant , Gastrointestinal Transit/drug effects , Male , Mice , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Sciatic Nerve/surgery , Spinal Cord/drug effects , Spinal Cord/metabolism , Stomach/anatomy & histology , Stomach/drug effects , Stomach/physiology
2.
J Ethnopharmacol ; 192: 210-216, 2016 Nov 04.
Article in English | MEDLINE | ID: mdl-27435374

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Vitex megapotamica (Spreng) Moldenke has been used in South American folk medicine to treat inflammatory diseases. However, the effects of V. megapotamica on animal models of nociception and depression have not been evaluated. AIM OF THE STUDY: This study investigated whether the crude leaf extract of V. megapotamica exhibits antinociceptive and antidepressant-like effects in a Freund's adjuvant-induced chronic inflammation and depression model. MATERIALS AND METHODS: Chronic inflammation was induced in rats by the intraplantar administration of complete Freund's adjuvant (CFA; 100µl). The effect of oral crude extract of V. megapotamica (VmE; 3-30mg/kg, p.o.) on nociception (thermal hyperalgesia, mechanical allodynia and arthritis score), inflammation (edema, myeloperoxidase activity), immobility (forced swimming test), locomotor activity (open field), gastrointestinal transit, hyperalgesia and naloxone-precipitated morphine withdrawal syndrome was evaluated. Naloxone (0.4mg/kg, i.p.) was used to investigate the involvement of opioid system in the currently described effects of VmE. RESULTS: Crude extract caused antinociceptive/antidepressant-like effects in the CFA-induced chronic inflammation model, which was prevented by naloxone. The VmE extract (10mg/kg, p.o.) did not alter the locomotor activity, gastrointestinal function and inflammatory parameters and did not cause hyperalgesia. CONCLUSION: V. megapotamica induces opioid-dependent antinociception and antidepressant-like effect, without anti-inflammatory activity. The results support the use of VmE as analgesic and antidepressant.


Subject(s)
Analgesics/pharmacology , Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Depression/prevention & control , Hyperalgesia/prevention & control , Motor Activity/drug effects , Nociception/drug effects , Plant Extracts/pharmacology , Vitex/chemistry , Administration, Oral , Analgesics/administration & dosage , Analgesics/isolation & purification , Animals , Antidepressive Agents/administration & dosage , Antidepressive Agents/isolation & purification , Depression/etiology , Depression/psychology , Disease Models, Animal , Freund's Adjuvant , Hyperalgesia/etiology , Hyperalgesia/physiopathology , Inflammation/chemically induced , Male , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Pain Threshold/drug effects , Phytotherapy , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Plants, Medicinal , Rats, Wistar , Reaction Time/drug effects , Swimming , Time Factors
3.
Inflammation ; 38(2): 606-15, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25120238

ABSTRACT

Vitamin E (vit-E) is a lipophilic antioxidant, and its anti-inflammatory activity is still not full characterized. Thus, our goal was to investigate the anti-inflammatory effect of repeated vit-E treatment in the arthritis induced by the intraplantar injection of complete Freund's adjuvant (CFA). We observed an increase in arthritis scores, interleukin-1ß and H2O2 levels, neutrophil and macrophage infiltration, thermal hyperalgesia, mechanical allodynia, and loss of function induced by intraplantar CFA injection. These effects were unaltered after 1 day, partially reversed after 3 days, and inhibited after 9 days after vit-E treatment. Furthermore, the concentration of vit-E was reduced and that of tumor necrosis factor-alpha was increased in the CFA-injected paw. Both effects were reversed from 1 to 9 days after vit-E treatment. However, vit-E treatment did not alter CFA-induced edema at any time. Thus, vit-E treatment produced an anti-inflammatory effect of slow onset in CFA, which demonstrates a disease-modifying drug profile.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/drug therapy , Hyperalgesia/drug therapy , Nociception/drug effects , Vitamin E/therapeutic use , Analgesics/therapeutic use , Animals , Antioxidants/therapeutic use , Arthritis, Experimental/chemically induced , Edema/drug therapy , Freund's Adjuvant , Hydrogen Peroxide/metabolism , Inflammation/drug therapy , Inflammation/immunology , Interleukin-1beta/metabolism , Macrophages/immunology , Male , Neutrophil Infiltration/drug effects , Neutrophils/immunology , Pain Measurement , Rats , Rats, Wistar , Skin/metabolism , Skin/pathology , Tumor Necrosis Factor-alpha/metabolism
4.
J Photochem Photobiol B ; 133: 47-54, 2014 Apr 05.
Article in English | MEDLINE | ID: mdl-24681774

ABSTRACT

Ultraviolet B (UVB) irradiation mainly affects biological tissues by inducing an increase in reactive oxygen species (ROS) production which leads to deleterious outcomes for the skin, including pain and inflammation. As a protective strategy, many studies have focused on the use of natural products. The aim of this study was to investigate the effects of Aloe saponaria on nociceptive, inflammatory, and oxidative parameters in a model of UVB-induced sunburn in adult male Wistar rats. Sunburned animals were topically treated with vehicle (base cream), 1% silver sulfadiazine (positive control) or A. saponaria (10%) once a day for 6days. UVB-induced nociception (allodynia and hyperalgesia), inflammation (edema and leukocyte infiltration) and oxidative stress (increases in H2O2, protein carbonyl levels and lipid peroxidation and a decrease in non protein thiol content) were reduced by both A. saponaria and sulfadiazine topical treatment. Furthermore, A. saponaria or its constituents aloin and rutin reduced the oxidative stress induced by H2O2 in skin homogenates in vitro. Our results demonstrate that topical A. saponaria treatment displayed anti-nociceptive and anti-inflammatory effects in a UVB-induced sunburn model, and these effects seem to be related to its antioxidant components.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Plant Extracts/pharmacology , Saponaria/chemistry , Skin/drug effects , Ultraviolet Rays , Analgesics/chemistry , Analgesics/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Antioxidants/chemistry , Antioxidants/therapeutic use , Chromatography, High Pressure Liquid , Disease Models, Animal , Emodin/analogs & derivatives , Emodin/analysis , Emodin/pharmacology , Emodin/therapeutic use , Inflammation/drug therapy , Male , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Plant Leaves/metabolism , Rats , Rats, Wistar , Saponaria/metabolism , Silver Sulfadiazine/chemistry , Skin/radiation effects , Sunburn/drug therapy , Time Factors
5.
J Ethnopharmacol ; 150(2): 458-65, 2013 Nov 25.
Article in English | MEDLINE | ID: mdl-24008111

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Viola tricolor, popularly known as heartsease has been empirically used in several skin disorders, including burns. AIM OF THE STUDY: The objective of this study was investigate the antinociceptive and antiinflammatory effect of a gel containing extract of Viola tricolor flowers on thermal burn induced by UVB irradiation and to perform gel stability study. METHODS: The antinociceptive and antiinflammatory effect were evaluated by static and dynamic mechanical allodynia model, paw edema, and neutrophilic cell infiltration. Metabolites compounds were quantified by HPLC. The gel stability study was performed analyzing organoleptical aspects, besides pH, viscosity, and quantification of rutin by HPLC. RESULTS: In the results were evidenced changes in threshold in statical and dynamic mechanical allodynia (I(max)=100 ± 10% and 49 ± 10%, respectively), paw edema (I(max)=61 ± 6%), and myeloperoxidase activity (I(max)=89 ± 5%). Such effects may be attributed, in part, to rutin, salicylic and chlorogenic acids, and others compounds found in this species. No important changes were detected in the stability study, in all aspects analyzed in temperature below 25 °C. CONCLUSION: These findings suggest that Viola tricolor gel has an antinociceptive and antiinflammatory effect in the ultraviolet-B-induced burn, since maintain the temperature below 25 °C.


Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Plant Extracts/therapeutic use , Sunburn/drug therapy , Viola , Animals , Disease Models, Animal , Drug Stability , Edema/drug therapy , Edema/immunology , Flowers , Gels , Hyperalgesia/drug therapy , Hyperalgesia/immunology , Male , Neutrophils/immunology , Rats , Rats, Wistar , Sunburn/immunology
6.
J Ethnopharmacol ; 146(1): 393-401, 2013 Mar 07.
Article in English | MEDLINE | ID: mdl-23333747

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: In Brazil, the plant Aloe saponaria Haw, popularly known as "babosa pintadinha", has been empirically used for its potential effect on thermal injury. Because there are no scientific data confirming its popular use, the aim of the present study was to investigate the effects of Aloe saponaria on nociceptive and inflammatory parameters in a rat model of thermal injury. MATERIALS AND METHODS: Adult male Wistar rats were subjected to a thermal injury or sham procedure (immersion in water at 70 or 37°C, respectively, for 5 or 8s). Burned animals were topically treated with vehicle (base cream), sulfadiazine 1% (positive control) or Aloe saponaria cream (0.3%-30%) once a day for 2 or 6 days. Each day, 30min before the treatment, we measured nociceptive (static and dynamic mechanical allodynia, thermal allodynia and spontaneous pain) and inflammatory (paw edema) parameters. Moreover, enzymatic indicators of leukocyte infiltration into burned tissue were also determined 2 or 6 days after the thermal injury. RESULTS: The thermal injury (fist and second-degree) procedure, but not the sham procedure, induced nociception and inflammation from 1 to 6 days after the injury. The topical treatment with Aloe saponaria cream (10%) reduced nociceptive behaviors from day 1 to 6 (peak at day 2), edema at days 5 and 6 (peak at day 6) and myeloperoxidase, N-acetyl-glucosaminidase and eosinoperoxidase activities at day 6. The antinociceptive and anti-inflammatory effects of Aloe saponaria were obtained with doses of 3%-30%, with maximal inhibition obtained with a dose of 10% (reductions of 39±9%, 41±9%, 31±7%, 83±7% and 23±2% for static and dynamic mechanical allodynia, thermal allodynia, spontaneous pain and paw edema, respectively). CONCLUSION: Our results demonstrate that topically applied Aloe saponaria presented antinociceptive and anti-inflammatory effects in rats subjected to a thermal injury, which supports its traditional use for burn injuries.


Subject(s)
Aloe , Analgesics/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Burns/drug therapy , Hyperalgesia/drug therapy , Plant Extracts/therapeutic use , Acetylglucosaminidase/metabolism , Analgesics/chemistry , Analgesics/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Behavior, Animal/drug effects , Burns/pathology , Burns/physiopathology , Edema/drug therapy , Edema/pathology , Edema/physiopathology , Eosinophil Peroxidase/metabolism , Flavonoids/isolation & purification , Hot Temperature , Hyperalgesia/pathology , Hyperalgesia/physiopathology , Male , Peroxidase/metabolism , Phenols/isolation & purification , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Leaves , Rats , Rats, Wistar
7.
J Pharmacol Exp Ther ; 343(2): 258-69, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22837009

ABSTRACT

The transient receptor potential vanilloid 1 (TRPV1) receptor is relevant to the perception of noxious information and has been studied as a therapeutic target for the development of new analgesics. The goal of this study was to perform in vivo and in vitro screens to identify novel, efficacious, and safe TRPV1 antagonists isolated from leaves of the medicinal plant Vernonia tweedieana Baker. All of the fractions and the hydroalcoholic extract produced antinociception in mice during the capsaicin test, but the dichloromethane fraction also had antioedematogenic effect. Among the compounds isolated from the dichloromethane fraction, only α-spinasterol reduced the nociception and edema induced by capsaicin injection. Moreover, α-spinasterol demonstrated good oral absorption and high penetration into the brain and spinal cord of mice. α-Spinasterol was able to displace [3H]resiniferatoxin binding and diminish calcium influx mediated by capsaicin. Oral administration of the dichloromethane fraction and α-spinasterol also produced antinociceptive effect in the noxious heat-induced nociception test; however, they did not change the mechanical threshold of naive mice. The treatment with α-spinasterol did not produce antinociceptive effect in mice systemically pretreated with resiniferatoxin. In addition, α-spinasterol and the dichloromethane fraction reduced the edema, mechanical, and heat hyperalgesia elicited by complete Freund's adjuvant paw injection. The dichloromethane fraction and α-spinasterol did not affect body temperature or locomotor activity. In conclusion, α-spinasterol is a novel efficacious and safe antagonist of the TRPV1 receptor with antinociceptive effect.


Subject(s)
Analgesics , Stigmasterol/analogs & derivatives , TRPV Cation Channels/antagonists & inhibitors , Vernonia/chemistry , Animals , Binding, Competitive/drug effects , Body Temperature/drug effects , Calcium/metabolism , Capsaicin/pharmacology , Chromatography, High Pressure Liquid , Diterpenes/metabolism , Edema/chemically induced , Edema/pathology , Freund's Adjuvant , Hot Temperature , Male , Mice , Nociceptors/drug effects , Pain/chemically induced , Pain/prevention & control , Pain Measurement/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Stigmasterol/pharmacokinetics , Stigmasterol/pharmacology , Tissue Distribution
8.
Inflamm Res ; 61(2): 103-12, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22057902

ABSTRACT

OBJECTIVE AND DESIGN: To investigate whether N-acetylcysteine (NAC) alters baker's-yeast-induced fever and inflammation. MATERIAL OR SUBJECTS: Male Wistar rats (26-28 days old) injected with baker's yeast (135 mg/kg, intraperitoneal) or prostaglandin E(2) (300 ng/100 µL, intrathecal). TREATMENT: Rats were injected with NAC (500 mg/kg, subcutaneous, or 50 µg/100 µL, intrathecal) 1 h before, or 2 h after, pyrogen injection. METHODS: Rectal temperature changes induced by baker's yeast, PGE(2) and NAC were followed up over time. Four hours after baker's yeast injection, total leukocytes, protein, interleukin (IL)-1ß, tumor necrosis factor (TNF)-α and nonprotein thiol content were assessed in peritoneal lavage and hypothalamus. RESULTS: Systemic administration of NAC decreased leukocytes, protein, IL-1ß and TNF-α levels in peritoneal lavage, and decreased IL-1ß levels in the hypothalamus. The central administration of NAC prevented baker's-yeast-induced fever, but did not alter the febrile response elicited by prostaglandin E(2). CONCLUSION: These results suggest an anti-inflammatory and antipyretic role for NAC in yeast-induced peritonitis.


Subject(s)
Acetylcysteine/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antipyretics/therapeutic use , Fever/drug therapy , Free Radical Scavengers/pharmacology , Peritonitis/drug therapy , Saccharomyces cerevisiae/drug effects , Acetylcysteine/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antipyretics/pharmacology , Dinoprostone/pharmacology , Fever/microbiology , Hypothalamus/chemistry , Hypothalamus/metabolism , Interleukin-1beta/analysis , Leukocyte Count , Male , Peritoneal Lavage , Peritonitis/metabolism , Peritonitis/microbiology , Proteins/analysis , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/analysis
9.
Biochem Pharmacol ; 81(4): 544-51, 2011 Feb 15.
Article in English | MEDLINE | ID: mdl-21087598

ABSTRACT

The transient potential vanilloid 1 receptor (TRPV1) is a calcium-permeable channel responsible for the transduction and modulation of acute and chronic pain signaling. As such, this receptor is a potential target for the treatment of a number of pain disorders. However, AMG517, a TRPV1 antagonist, presents several clinical limitations that include the induction of severe hyperthermia. The aim of this study was to investigate the possible interaction of the flavonoid eriodictyol with the TRPV1 receptor and to determine its putative antinociceptive and hyperthermic effects. Eriodictyol was able to displace [(3)H]-resiniferatoxin binding (IC(50)=47; 21-119nM) and to inhibit calcium influx mediated by capsaicin (IC(50)=44; 16-125nM), suggesting that eriodictyol acts as a TRPV1 antagonist. Moreover, eriodictyol induced antinociception in the intraplantar capsaicin test, with maximal inhibition of 49±10 and 64±4% for oral (ID(50)=2.3; 1.1-5.7mg/kg) and intrathecal (ID(50)=2.2; 1.7-2.9nmol/site) administration, respectively. Eriodictyol did not induce any change in body temperature or locomotor activity. Orally administered eriodictyol (4.5mg/kg) prevented the nociception induced by intrathecal injections of capsaicin, as well as the non-protein thiol loss and 3-nitrotyrosine (3-NT) formation induced by capsaicin in spinal cord. Eriodictyol also reduced the thermal hyperalgesia and mechanical allodynia elicited by complete Freund's adjuvant (CFA) paw injection. In conclusion, eriodictyol acts as an antagonist of the TRPV1 receptor and as an antioxidant; it induces antinociception without some of the side effects and limitations such as hyperthermia that are expected for TRPV1 antagonists.


Subject(s)
Flavanones/pharmacology , Pain/drug therapy , TRPV Cation Channels/antagonists & inhibitors , Analgesics/administration & dosage , Analgesics/adverse effects , Analgesics/pharmacology , Animals , Antioxidants , Capsaicin/pharmacology , Flavanones/administration & dosage , Flavanones/adverse effects , Flavonoids , Hyperalgesia/drug therapy , Mice , Rats
10.
J Pain ; 11(6): 545-54, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20356800

ABSTRACT

UNLABELLED: Oxidative stress markers are thought to be related to nociception. Because thiolic compounds are important antioxidants, we investigated the relationship between thiols, endogenous or exogenous, and nociception. Systemic or spinal, but not peripheral, administration of the exogenous thiolic compound N-acetyl-L-cysteine (NAC) reduced nociception induced by intraplantar capsaicin injection. Moreover, we detected an increase in lipid peroxidation and 3-nitrotyrosine and a decrease in nonprotein thiolic levels in the lumbar spinal cord of capsaicin-injected animals. All these effects were prevented by NAC treatment (i.p. and i.t.). Our findings confirm a role for the spinal cord in NAC actions because systemic NAC administration also reduced the nociception trigged by intrathecal injection of capsaicin. Moreover, adjuvant-induced arthritis, but not paw incision, also -decreases nonprotein thiol levels in the spinal cord. Similarly, NAC produced antinociception in adjuvant-treated animals, but not in paw-incised animals. Finally, we investigated the role of endogenous thiol compounds in the nociceptive process administrating buthionine-suphoxamine (BSO), an inhibitor of glutathione-synthesis. Intrathecal BSO treatment decreased nonprotein thiol levels in the spinal cord, as well as induced mechanical allodynia and chemical and thermal hyperalgesia. In conclusion, our results indicate a critical role for nonprotein thiols in nociception at the level of the spinal cord. PERSPECTIVE: The results presented here indicate that the loss of nonprotein thiols in the spinal cord is involved in pain development. Therefore, the administration of thiolic compounds or other strategies allow thiol levels to be maintained and could be a beneficial action in the therapy of painful conditions.


Subject(s)
Pain/metabolism , Spinal Cord/metabolism , Sulfhydryl Compounds/metabolism , Acetylcysteine/administration & dosage , Acetylcysteine/pharmacology , Acute Disease , Analgesics/administration & dosage , Analgesics/pharmacology , Animals , Antimetabolites/pharmacology , Arthritis, Experimental/complications , Arthritis, Experimental/drug therapy , Arthritis, Experimental/metabolism , Behavior, Animal/drug effects , Buthionine Sulfoximine/pharmacology , Capsaicin , Disease Models, Animal , Female , Foot Injuries/complications , Foot Injuries/drug therapy , Foot Injuries/metabolism , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Lumbar Vertebrae , Male , Mice , Oxidative Stress/drug effects , Oxidative Stress/physiology , Pain/drug therapy , Pain/etiology , Spinal Cord/drug effects , Sulfhydryl Compounds/administration & dosage , Sulfhydryl Compounds/pharmacology
11.
J Ethnopharmacol ; 127(2): 299-305, 2010 Feb 03.
Article in English | MEDLINE | ID: mdl-19914369

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: In Southern Brazil, the plant Campomanesia xanthocarpa Berg. (Myrtaceae), popularly known as "guavirova", has been empirically used for its potential effect in reducing blood cholesterol levels. AIM OF THE STUDY: Since there are no scientific data confirming its popular use, the aim of the present study was to investigate the effect of Campomanesia xanthocarpa on biochemical, hematological, anthropometrical and oxidative stress parameters in hypercholesterolemic patients. MATERIALS AND METHODS: Thirty three patients were selected according to total cholesterol (TC) levels: 200-240 mg/dL, undesirable level (UL), and >240 mg/dL, hypercholesterolemic level (HL). UL or HL patients were randomly divided into control group (CG), which received placebo capsules, and experimental group 250 (EG 250) or 500 (EG 500), which received either 250 or 500 mg of encapsulated Campomanesia xanthocarpa. All groups received a cholesterol restriction diet and capsules once a day. The biochemical (TC, triglycerides, HDL, LDL and VLDL), hematological (hematocrit and hemoglobin), anthropometrical (weight and abdominal circumference) and oxidative stress (protein carbonyl) parameters were measured before, 45 and 90 days after the treatment started. RESULTS: There was no alteration on biochemical, hematological, anthropometric or oxidative stress parameters in UL patients of all groups. However, a significant decrease in TC and LDL levels was observed in HL patients from EG 500 group (reduction of 28+/-3% and 45+/-4% to levels before treatment) in relation to CG group patients (reduction of 12+/-2% and 29+/-4%). Moreover, a significant reduction in oxidative stress was observed in HL patients of EG 250 (51+/-12%) and EG 500 groups (34+/-18%) when compared to levels before treatment. A positive correlation between plasma oxidative stress PC and TC levels was observed. Finally, we found that Campomanesia xanthocarpa extract possesses anti-oxidant properties and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitory activity in vitro. CONCLUSION: Confirming its popular use, the treatment with Campomanesia xanthocarpa encapsulated reduced blood TC and LDL levels in hypercholesterolemic patients.


Subject(s)
Hypercholesterolemia/blood , Hypercholesterolemia/drug therapy , Meliaceae/chemistry , Meliaceae/physiology , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Adult , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Oxidative Stress/physiology , Plant Extracts/blood , Plant Leaves
SELECTION OF CITATIONS
SEARCH DETAIL